SCHEMBL8483452

SCHEMBL8483452

O=S(=O)(NC1CCCCC1)C1CCNCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.50
CA7 P43166 3/20 0.50
CA14 Q9ULX7 3/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 1/20 0.47
EPHX1 P07099 1/20 0.46
CA9 Q16790 1/20 0.45
CYP3A4 P08684 2/20 0.43
TSHR P16473 2/20 0.43
LMNA P02545 1/20 0.43
GABRA1 P14867 1/20 0.43
GABRG2 P18507 1/20 0.43
NFKB1 P19838 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA5 P31644 1/20 0.43
GABRA3 P34903 1/20 0.43
GABRA2 P47869 1/20 0.43
GABRA6 Q16445 1/20 0.43
KDM4E B2RXH2 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28419752 0.94 CYP3A4 (0.45) CA12CA7CA14CA1CA2
SCHEMBL16364952 0.90 GABRA1 (0.48) CA12CA7CA14CA1CA2
SCHEMBL27994463 0.85 GABRA1 (0.43) CA12CA7CA14CA1CA2
SCHEMBL11134361 0.85 CA12 (0.61) CA12CA7CA14CA1CA2
SCHEMBL6057631 0.85 CA12 (0.61) CA12CA7CA14CA1CA2
SCHEMBL1048715 0.85 CA12 (0.61) CA12CA7CA14CA1CA2
Hydrochloric Acid SCHEMBL13386291 0.83 LMNA (0.41) CA12CA7CA14CA1CA2
SCHEMBL18855930 0.83 CA12 (0.56) CA12CA7CA14CA1CA2
SCHEMBL28413065 0.82 CA12 (0.52) CA12CA7CA14CA1CA2
SCHEMBL28410020 0.79 CA12 (0.48) CA12CA7CA14CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5925635-A 2-(OXO-1,3-PERHYDRODIAZEPINES OR 3-OXO-2,3,4,5-TETRAHYDRO-1H-2,4-BENZODIAZEPINES; ANTICOAGULANTS; ENZYME INHIBITORS OF SERINE PROTEASE THROMBIN, KALLIKREIN AND PLASMIN; NERVOUS SYSTEM DISORDERS; ANTIINFLAMMATORY AGENTS DUPONT PHARMACEUTICALS COMPANY (US) 1999-07-20 US disclosed